- Patent Title: Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for mitigation and/or treatment of pneumonitis/pneumonia/pulmonary fibrosis induced by virus infection and/or by chemical or biological agents
-
Application No.: US17170388Application Date: 2021-02-08
-
Publication No.: US11672772B2Publication Date: 2023-06-13
- Inventor: Lurong Zhang
- Applicant: Lurong Zhang
- Applicant Address: US MD Bethesda
- Assignee: Lurong Zhang
- Current Assignee: Lurong Zhang
- Current Assignee Address: US MD Bethesda
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Main IPC: A61K31/19
- IPC: A61K31/19 ; A61K31/14 ; A61K31/704 ; A61P31/14
Abstract:
The present invention pertains to novel uses of glycyrrhetinic acid (GA), glycyrrhizic acid (GR) and related compounds for mitigation and/or treatment of pneumonitis/pneumonia/pulmonary fibrosis induced by various chemicals/bioagents and/or pathogens, such as anti-cancer therapies and/or virus.
Also embodied are therapeutic uses of prodrugs, metabolites, derivatives (e.g., acids, esters and ethers), and salts of glycyrrhetinic acid (GA) and glycyrrhizic acid (GR) in a form of drugs, health products, foods or food additives.
Also embodied are therapeutic uses of prodrugs, metabolites, derivatives (e.g., acids, esters and ethers), and salts of glycyrrhetinic acid (GA) and glycyrrhizic acid (GR) in a form of drugs, health products, foods or food additives.
Public/Granted literature
Information query
